Peptide Library / Detail
Adipotide
Half-life
2–4 hours (in animal studies; human data not established)
Delivery
Subcutaneous injection (for research use only)
Dosage
—
Research Use Only
All products listed are for laboratory research only — not for human consumption. By browsing, you acknowledge these terms.
Purchase
Description
Adipotide, also known as FTPP (Fat Targeted Proapoptotic Peptide), is an experimental peptide designed to induce targeted apoptosis of fat cells, potentially resulting in rapid reduction of body fat in animal studies.
Usage
Primarily used in research settings to investigate its effects on body weight reduction, fat loss, and metabolic health. Not approved for human use.
Mechanism of Action
Adipotide targets specific proteins on the surface of fat cell blood vessels (Prohibitin and ANXA2), causing apoptosis (cell death) in the blood vessels supplying white adipose tissue. This leads to fat cell death and subsequent reduction of fat mass.
Benefits(4)
- Rapid fat loss observed in animal studies
- Reduces white adipose tissue
- Potential metabolic improvements (e.g., insulin sensitivity)
- Non-stimulant fat loss mechanism
Side Effects(4)
- Dehydration
- Mild to moderate kidney stress (noted in primate studies)
- Electrolyte imbalance
- Potential for nausea, lethargy, and other systemic effects